The Rising Admin Complexity of Psychedelic-Assisted Therapy
Ketamine-assisted therapy and esketamine (Spravato) programs are among the fastest-growing segments of the mental health treatment landscape. Clinics offering these services — standalone ketamine infusion practices, psychiatric practices with Spravato REMS programs, and emerging psilocybin-assisted therapy programs in states where legal — face an administrative model that is substantially more complex than standard outpatient therapy.
The intake pipeline alone is multi-stage: a patient must complete a detailed medical and psychiatric questionnaire, pass a pre-screening call with a clinician, receive a psychiatric evaluation, sign a multi-page informed consent specific to ketamine or psychedelic-assisted treatment, and coordinate the logistics of a session that typically involves a preparation appointment, the treatment session itself (which may last several hours), and a structured integration session afterward. According to the Multidisciplinary Association for Psychedelic Studies' 2025 Clinical Practice Survey, psychedelic-assisted therapy programs report an average of 7–10 administrative touchpoints per patient before the first treatment session — compared to 2–3 for standard outpatient therapy.
A virtual assistant who understands this model manages the administrative layer without requiring clinical training in psychedelic therapy itself.
Eligibility Pre-Screening Administration
Most ketamine and psychedelic-assisted therapy clinics use a structured pre-screening process to determine whether a prospective patient is an appropriate candidate before investing clinical time in a full evaluation. This typically involves a written questionnaire covering psychiatric history, current medications, cardiovascular history (relevant for ketamine), substance use history, and treatment goals. Collecting, organizing, and reviewing this information before the intake call is an administrative function — confirming receipt, following up on incomplete responses, and preparing the completed questionnaire for the clinician's review.
A VA manages this pipeline: sending the pre-screening form through SimplePractice or the clinic's intake platform, tracking submission status, following up with prospective patients who have not completed the form within a defined window, and organizing completed pre-screens into a review queue for the evaluating clinician. When a pre-screen reveals an obvious exclusion criterion — a contraindicated medication, a stated psychotic history — the VA flags it for clinical review before the patient is scheduled for an evaluation, preventing a costly clinical hour from being consumed by a patient who is not a fit.
Consent Documentation Tracking
Informed consent for ketamine-assisted therapy is not a single-signature event. A comprehensive consent process typically involves a written informed consent document covering the nature of the treatment, risks, alternatives, and the clinic's specific protocol; a Spravato REMS enrollment form if the program includes esketamine; a release authorizing coordination with the prescribing physician; and any integration therapy consent if a paired therapist is involved in the treatment model.
A VA tracks each consent document by patient through the full signature sequence. In platforms like DocuSign integrated with SimplePractice, or through the clinic's native consent management system, the VA confirms that each document has been signed before the treatment session is scheduled. When a document is missing or incomplete, the VA sends a reminder with the document link rather than letting the omission surface on treatment day — where it would either delay the session or create a compliance gap.
According to the American Society of Ketamine Physicians, Psychotherapists and Practitioners' 2025 Standards of Care Update, documentation gaps in ketamine consent processes represent the most common compliance finding in program audits.
Post-Treatment Follow-Up Coordination
Psychedelic-assisted therapy protocols are designed with structured follow-up. After a ketamine infusion or Spravato treatment session, patients typically receive a follow-up call at 24–48 hours, a structured integration session within the week, and a clinical check-in at defined intervals. Coordinating this cadence across a full patient panel — especially as the clinic scales — requires a systematic follow-up workflow that clinical staff cannot reliably manage on top of treatment delivery.
A VA manages the follow-up schedule: sending appointment links for integration sessions, confirming follow-up calls on the patient's calendar, sending post-session check-in forms at the 24-hour mark, and flagging any patient who has not responded to a follow-up touchpoint within the expected window. They do not conduct clinical check-ins — those remain with the treating clinician — but they ensure the logistics are in place so no patient falls through the post-treatment gap.
If your ketamine or psychedelic-assisted therapy clinic is scaling and the admin is getting ahead of the clinical team, hire a virtual assistant for your psychedelic therapy clinic and build the operational foundation your program needs.
Sources
- Multidisciplinary Association for Psychedelic Studies. (2025). Clinical Practice Survey: Administrative Touchpoints in Psychedelic-Assisted Therapy Programs. MAPS.
- American Society of Ketamine Physicians, Psychotherapists and Practitioners. (2025). Standards of Care Update: Consent and Documentation Requirements. ASKP3.
- SimplePractice. (2025). Intake Workflow and Consent Tracking for Specialty Mental Health Clinics. SimplePractice.
- U.S. Food and Drug Administration. (2025). Spravato REMS Program Requirements for Certified Healthcare Settings. FDA.